Investigator-selected chemotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Investigator-selected chemotherapy, covering 2026-04-20 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: A Multicohort Study of Toripalimab in Combination With Investigator-Selected Chemotherapy for Advanced HER2-Negative Breast Cancer [Phase 2]